Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia

American Journal of Geriatric Psychiatry

Volumn 15, Issue 12, 2007, Pages 1005-1014

  Zisook, Sidney ^a,d   Montross, Lori ^a   Kasckow, John ^b   Mohamed, Somaia ^c   Palmer, Barton W ^a   Patterson, Thomas L ^a   Golshan, Shahrokh ^a   Fellows, Ian ^a   Lehman, David ^a   Solorzano, Ellen ^a  

^a Department of Psychiatry ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Depressive symptoms; Schizophrenia; Subsyndromal depression

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; NEUROLEPTIC AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; AKATHISIA; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; FEMALE; GERIATRICS; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL FUNCTION; MIDDLE AGED; MORBIDITY; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; PERSONAL EXPERIENCE; POSITIVE SYNDROME; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SENESCENCE; SUBSYNCROMAL DEPRESSIVE SYMPTOM; SUBSYNDROMAL DEPRESSIVE SYMPTOM; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYMPTOM; TREATMENT DURATION; UNITED STATES; UNIVERSITY; AGE; CHRONIC DISEASE; COMORBIDITY; COMPARATIVE STUDY; FOLLOW UP; HEALTH STATUS; MAJOR DEPRESSION; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; STATISTICS; SUICIDE; TREATMENT OUTCOME;

AGE FACTORS; CHRONIC DISEASE; CITALOPRAM; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEROTONIN UPTAKE INHIBITORS; SUICIDE; TREATMENT OUTCOME;

EID: 38449100222     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3180a725ec     Document Type: Article

References (45)

1. Cohen CI: Studies of the course and outcome of schizophrenia in later life. Psychiatr Serv 1995; 46:877-889
2. Jin H, Zisook S, Palmer BW, et al: Association of depressive symptoms and functioning in schizophrenia: a study in older outpatients. J Clin Psychiatry 2001; 62:797-803
3. Kelly DL, Shim JC, Feldman SM, et al: Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death. J Psychiatr Res 2004; 38:531-536
4. Zisook S, McAdams LA, Kuck J, et al: Depressive symptoms in schizophrenia. Am J Psychiatry 1999; 156:1736-1743
5. Auguier P, Lancon C, Rouillon F, et al: Mortality in schizophrenia. Pharmacoepidemiol Drug Safety 2006; 15:873-879
6. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66:802-813
7. Schwartz RC, Cohen BN: Psychosocial correlates of suicidal intent among patients with schizophrenia. Comp Psychiatry 2001;42:118-123
8. Joukamaa M, Heliovaara M, Knekt P, et al: Mental disorders and cause-specific mortality. Br J Psychiatry 2001; 179:498-502
9. Siris SG, Addington D, Azorin JM, et al: Depression in schizophrenia: recognition and management. Schizophr Res 2001; 47:185-197
10. Glick ID, Balon R, Zisook S, et al: ASCP Model Psychopharmacology Curriculum, 4th Ed. New York, American Society of Clinical Psychopharmacology, 2006
11. Robins LN, Regier DA: Psychiatric disorders in America: the epidemiological catchment area study. New York, Free Press, 1991
12. Kessler RC, McGonagle KA, Zhao S, et al: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry 1994; 51:8-19
13. Birchwood M, Mason R, Macmillan F, et al: Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with chronic psychosis. Psychol Med 1993; 23:387-395
14. Roy A, Thompson R, Kennedy S: Depression in chronic schizophrenia. Br J Psychiatry 1983; 142:465-470
15. DeHert M, McKenzie K, Peuskens J: Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res 2001; 47:127-134
16. Leff J: Depressive Symptoms in the Course of Schizophrenia. Depression in Schizophrenia. Washington DC, American Psychiatric Press, 1990
17. Bartels SJ, Drake RE: Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 1988; 29:467-483
18. Tollefson GD, Sanger TM, Lu Y, et al: Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry 1998; 55:250-258
19. Kay SR, Sevy S: Pyramidal model of schizophrenia. Schizophr Bull 1990; 16:537-545
20. Sands JR, Harrow M: Depression during the longitudinal course of schizophrenia. Schizophr Bull 1999; 25:157-171
21. Serretti A, Mandelli L, Lattuada E, et al: Depressive syndrome in major psychoses: a study on 1351 subjects. Psychiatry Res 2004; 127:85-99
22. Tollefson GD, Anderson SW, Tran PV: The course of depressive symptoms in predicting relapse in schizophrenia: a doubleblinded, randomized comparison of olanzapine and risperidone. Biol Psychiatry 1999; 46:365-373
23. Caldwell CB, Gottesman I: Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull 1990; 16:571-589
24. Fenton WS: Depression, suicide, and suicide prevention in schizophrenia. Suicide Life Threat Behav 2000; 30:34-49
25. Gupta S, Black DW, Arndt S, et al: Factors associated with suicide attempts among patients with schizophrenia. Psychiatr Serv 1998; 49:1353-1355
26. Girling DM, Huppert FA, Brayne C, et al: Depressive symptoms in the very elderly: their prevalence and significance. Int J Geriatr Psychiatry 1995; 10:497-504
27. Judd LL, Akiskal HS, Maser JD, et al: A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998; 55:694-700
28. Judd LL, Akiskal HS, Paulus MP: The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar depressive disorder. J Affect Disord 1997; 45:5-17
29. Katona CLE: Depression in old age. New York, John Wiley & Sons, 1994
30. Lyness JM, King DA, Cox C, et al: The importance of subsyndromal depression in older primary care patients: prevalence and associated functional disability. J Am Geriatr Soc 1999; 47:647-652
31. Steffens DC, Skoog I, Norton MC, et al: Prevalence of depression and its treatment in an elderly population. Arch Gen Psychiatry 2000; 57:601-607
32. Appelbaum PS, Grisso T: The MacArther Competence Assessment Tool - Clinical Research. Sarasota, FL, Professional Resource Press, 1996
33. Dunn LB: Capacity to consent to research: the expanding evidence base. Behav Sci Law 2006; 24:431-445
34. Judd LL, Schettler P, Akiskal H: The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr Clin North Am 2002; 25:685-698
35. Rubin DB, Thomas N: Matching using estimated propensity scores: relating theory to practice. Biometrics 1996; 52:249-264
36. Hansen BB, Klopfer SO: Optimal full matching and related designs via network flows. J Comput Graph Stat 2006; 15:609-627
37. Spitzer RL, Williams JB, Gibbon M, et al: The structured clinical interview for the DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992; 49:624-629
38. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 233:56-62
39. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
40. Wells KB, Stewart A, Hays RD, et al: The functioning and wellbeing of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 263:659-660
41. Linn BS, Linn MW, Gurel L: Cumulative Illness Rating Scale. J Am Geriatr Soc 1968; 16:622-626
42. Miller MD, Paradis CF, Houck PR, et al: Rating chronic illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41:237-248
43. Miller MD, Towers A: A Manual of Guidelines for Scoring the Cumulative Rating Scale for Geriatrics (CIRS-G). Pittsburgh, University of Pittsburgh, 1991
44. Lane RD, Glazer WM, Hansen TE, et al: Assessment of tardive dyskinesia using the abnormal involuntary movement scales. J Nerv Mental Dis 1985; 173:353-357
45. Barnes TR: A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154:672-676